FDA issues warning letters to breast implant manufacturers days before hearing

In the letters, the US Food and Drug Administration reprimanded Mentor and Sientra for historically failing to complete the safety studies required for medical devices to stay on the market.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news